These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8842494)

  • 1. Bladder cancer angiogenesis, its role in recurrence, stage progression and as a therapeutic target.
    Crew JP; O'Brien TS; Harris AL
    Cancer Metastasis Rev; 1996 Jun; 15(2):221-30. PubMed ID: 8842494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of hypoxia-inducible factor 1alpha overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma.
    Theodoropoulos VE; Lazaris AC; Kastriotis I; Spiliadi C; Theodoropoulos GE; Tsoukala V; Patsouris E; Sofras F
    BJU Int; 2005 Feb; 95(3):425-31. PubMed ID: 15679808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of pericytes, hypoxia, and vascularity in bladder tumors: association with clinical outcomes.
    O'Keeffe MB; Devlin AH; Burns AJ; Gardiner TA; Logan ID; Hirst DG; McKeown SR
    Oncol Res; 2008; 17(3):93-101. PubMed ID: 18669161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of angiogenesis in nonmuscle invasive bladder cancer as defined by microvessel density after immunohistochemical staining for CD34.
    Ajili F; Kacem M; Tounsi H; Darouiche A; Enayfer E; Chebi M; Manai M; Boubaker S
    Ultrastruct Pathol; 2012 Oct; 36(5):336-42. PubMed ID: 22574784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of angiogenesis in superficial bladder cancer.
    Stavropoulos NE; Bouropoulos C; Ioachim IE; Michael M; Hastazeris K; Tsimaris I; Kalogeras D; Liamis Z; Stefanaki S; Agnantis NI
    Int Urol Nephrol; 2004; 36(2):163-7. PubMed ID: 15368686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression.
    Grossfeld GD; Ginsberg DA; Stein JP; Bochner BH; Esrig D; Groshen S; Dunn M; Nichols PW; Taylor CR; Skinner DG; Cote RJ
    J Natl Cancer Inst; 1997 Feb; 89(3):219-27. PubMed ID: 9017002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer.
    Crew JP; O'Brien T; Bradburn M; Fuggle S; Bicknell R; Cranston D; Harris AL
    Cancer Res; 1997 Dec; 57(23):5281-5. PubMed ID: 9393750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis.
    Bochner BH; Cote RJ; Weidner N; Groshen S; Chen SC; Skinner DG; Nichols PW
    J Natl Cancer Inst; 1995 Nov; 87(21):1603-12. PubMed ID: 7563203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers for recurrence of superficial bladder cancer: what is valid?
    van der Poel HG
    Curr Opin Urol; 1999 Sep; 9(5):401-6. PubMed ID: 10579077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor: an important angiogenic mediator in bladder cancer.
    Crew JP
    Eur Urol; 1999 Jan; 35(1):2-8. PubMed ID: 9933788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-a2b reduces neo-microvascular density in the 'normal' urothelium adjacent to the tumor after transurethral resection of superficial bladder carcinoma.
    Giannopoulos A; Adamakis I; Evangelou K; Giannopoulou M; Zacharatos P; Zsantoulis P; Perunovic B; Athanasiou A; Retalis G; Constandinidis C; Gorgoulis VG
    Onkologie; 2003 Apr; 26(2):147-52. PubMed ID: 12771523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bladder wash cytology at diagnosis of Ta-T1 bladder cancer is predictive for recurrence and progression.
    Jancke G; Rosell J; Chebil G; Jahnson S
    Urology; 2012 Sep; 80(3):625-31. PubMed ID: 22925239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship among cystectomy, microvessel density and prognosis in stage T1 transitional cell carcinoma of the bladder.
    Dinney CP; Babkowski RC; Antelo M; Perrotte P; Liebert M; Zhang HZ; Palmer J; Veltri RW; Katz RL; Grossman HB
    J Urol; 1998 Oct; 160(4):1285-90. PubMed ID: 9751337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prediction of tumor recurrence and progression of superficial bladder carcinoma using an artificial neural network].
    Planz B; Deix T; Caspers HP
    Urologe A; 2007 Sep; 46(9):1138-9. PubMed ID: 17668171
    [No Abstract]   [Full Text] [Related]  

  • 15. Predictors of outcome in bladder cancer.
    Eifler JB; Barocas DA; Resnick MJ
    J Natl Compr Canc Netw; 2014 Nov; 12(11):1549-54. PubMed ID: 25361801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 and microvessel density in primary resection specimens of superficial bladder cancer.
    Reiher F; Ozer O; Pins M; Jovanovic BD; Eggener S; Campbell SC
    J Urol; 2002 Mar; 167(3):1469-74. PubMed ID: 11832772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [One molecule, two faces. Epithelial loss of cell adhesion molecule CEACAM1 activates angiogenesis in bladder and prostate cancer].
    Tilki D; Oliveira-Ferrer L; Kilic N; Friedrich MG; Stief CG; Ergun S
    Urologe A; 2007 Sep; 46(9):1128-34. PubMed ID: 17605118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer.
    Jaeger TM; Weidner N; Chew K; Moore DH; Kerschmann RL; Waldman FM; Carroll PR
    J Urol; 1995 Jul; 154(1):69-71. PubMed ID: 7539869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil-to-lymphocyte ratio predicts progression and recurrence of non-muscle-invasive bladder cancer.
    Kaynar M; Goktas S
    Urol Oncol; 2015 Nov; 33(11):497. PubMed ID: 26092558
    [No Abstract]   [Full Text] [Related]  

  • 20. Does angiogenesis predict recurrence in superficial transitional cell carcinoma of the bladder?
    Sağol O; Yörükoğlu K; Sis B; Tuna B; Ozer E; Güray M; Mungan U; Kirkali Z
    Urology; 2001 May; 57(5):895-9. PubMed ID: 11337289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.